New Delhi, July 18
The ICMR will conduct a multi-centric examine to evaluate whether or not the BCG vaccine, used in opposition to tuberculosis, can stop the prevalence of coronavirus an infection and cut back the severity of the illness and mortality amongst aged people residing in hotspot areas.
The examine shall be carried out in Tamil Nadu, Maharashtra, Gujarat, Madhya Pradesh, Rajasthan and Delhi in roughly 1,500 wholesome volunteers above 60-years of age, an ICMR scientist mentioned.
Sanction has already been accorded to the trial by the ICMR’s National Institute for Research in Tuberculosis (NIRT) in Chennai by the Tamil Nadu authorities on July 15 to review the efficacy of BCG vaccine within the aged.
The BCG-COVID trial, beneath the auspices of ICMR can be held in 5 different centres—National Institute of Occupational Health, Ahmedabad, National Institute for Research in Environmental Health in Bhopal, GS Medical College and KEM Hospital in Mumbai, National Institute for Implementation Research on Non-Communicable Diseases in Jodhpur and AIIMS, New Delhi.
“As a part of this multi-centric study which will be carried out at six sites, elderly people not affected by coronavirus infection, will be given the Bacille Calmette Guerin (BCG) vaccine. The same BCG vaccine that is administered to newborn babies as a part of National Immunisation programme for more than 50 years in the country will be used in this study,” the ICMR scientist mentioned.
“The objective is to see if the shots can prevent the occurrence of the coronavirus infection and reduce the severity of the disease and mortality rate among the elderly individuals residing in hotspot areas,” the scientist mentioned.
There are pre-set standards within the examine that can resolve on eligibility of a volunteer to take part on this examine.
The volunteers can be adopted up intently for a interval of six months publish vaccination.
Those vaccinated can be adopted up and if a few of them get contaminated with COVID-19 afterward, it will be assessed if the BCG vaccination stood them in good stead when put next with others of the identical age group who weren’t vaccinated. — PTI